According to the latest research by Future Market Insights, Rapid Hepatitis Testing Market is expected to witness robust growth with 4-5% CAGR during the forecast period from 2021 to 2031. The rising prevalence of hepatitis caused due to liver infection and an increasing focus on molecular diagnostics is likely fuelling the global rapid hepatitis testing market growth. Therefore, growth at a significantly high CAGR will be expected soon.
What is Driving the Demand for Rapid Hepatitis Testing?
The availability of advanced diagnostic procedures for hepatitis tastings expects to boost the market growth in the coming years. The paradigm shift of the researchers and manufacturers to molecular diagnostics from conventional technologies has amplified the capability of procedures that has minimized the testing time.
For example, molecular diagnostics detect the presence of a virus that is involved by performing genetic tests to confirm the exact strain of the causative virus. Furthermore, the rising prevalence of hepatitis among the growing population is also expected to fuel market growth.
According to World Health Organization (WHO), around 325 million people are living with hepatitis B and/or C, and for most globally. To reduce the current global burden of hepatitis, the key players have increased focus on research area efforts to develop an effective rapid test that enables virus identification and eases linkage to various healthcare setting. For instance, in February 2019, Abbott has received CE Mark for the Determine™ HBsAg 2 test, the most sensitive rapid diagnostic test used for hepatitis B surface antigen detection.
To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13367
COVID-19 Impact on Rapid Hepatitis Testing Market Growth
The COVID-19 pandemic projected a significant impact on the rapid hepatitis testing market. Countrywide lockdown, disruption in supply chain and halt on transportation subjected product shortage. Global demand for vaccination led the manufacturers to focus on the vaccine production that has likely decreased the production of the other products that has no emergency headed significant impact on the rapid hepatitis testing market growth.
The U.S. and Canada Rapid Hepatitis Testing Market Outlook
U.S. and Canada will hold the top position in the rapid hepatitis testing market due to the rising prevalence of viral infection, the number of hepatitis cases caused due to change in lifestyle, and high consumption of alcohol, drug or toxins in the American countries. According to the Centre OF Disease and Control (CDC) total 18,846 of hepatitis A, a total of 3,192 acute hepatitis B, and around 4,136 acute hepatitis C cases were reported in 2019.
Europe Demand Outlook for Rapid Hepatitis Testing
Europe holds the second-most position in the rapid hepatitis testing market due to the growing number of hepatitis cases in the European countries. According to WHO European Region, in 2019, around 15 million people living with hepatitis B affects lives of infection. Central Europe has the high per cent of cases around 6-8% of people living with Hepatitis B, while western, northern and central European countries has less than 0.1% of cases.
Who are the Key Players of Rapid Hepatitis Testing Market?
Some of the leading players in the rapid hepatitis testing market include
- Abbott Laboratories
- Siemens Healthcare GmbH
- Bio-Rad Laboratories, Inc.
- Bayer AG
- CTK Biotech, Inc.
- QIAGEN
- Thermo Fisher Scientific Inc.
- BioGenex
- Biochrome Scientific
For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13367
Why Future Market Insights?
- Comprehensive analysis on evolving purchase pattern across different geographies
- Detailed insights of market segments and sub-segments for historical as well as forecast period
- A competitive analysis of prominent players and emerging players in the keyword market
- Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com